Literature DB >> 6108142

Evidence against beta-adrenoceptor blocking activity of diltiazem, a drug with calcium antagonist properties.

M Briley, I Cavero, S Z Langer, A G Roach.   

Abstract

1 The isolated spontaneously beating atria of the rat, diltiazem (0.01 to 0.1 microM) shifted the atrial rate concentration-response curves to isoprenaline to the right in a non-parallel manner and depressed their maxima. Under the same experimental conditions, (+/-)-propranolol (0.03 to 0.1 microM) behaved as a competitive beta-adrenoceptor antagonist. 2 Whereas (+/-)-propranolol (IC50 = 12 nM) and isoprenaline (IC50 = 0.9 microM) inhibited (-)-[3H]-dihydroalprenolol binding to rat brain membrane preparations, diltiazem failed to do so in concentrations up to 10 microM. 3 Diltiazem but not (+/-)-propranolol, antagonized the positive chronotropic responses to calcium in spontaneously beating rat atria. 4 It is proposed that diltiazem inhibited the tachycardia induced by isoprenaline through an effect on calcium which may be an essential modulator of the sequence of events linking the beta-adrenoceptor activation and heart rate response.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6108142      PMCID: PMC2044294          DOI: 10.1111/j.1476-5381.1980.tb07920.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  Direct identification and characterisation of beta-adrenergic receptors in rat brain.

Authors:  R W Alexander; J N Davis; R J Lefkowitz
Journal:  Nature       Date:  1975-12-04       Impact factor: 49.962

2.  Effect of diltiazem on the transmembrane potential of isolated guinea pig taenia coli.

Authors:  T Magaribuchi; H Nakajima; H Takenaga; A Kiyomoto
Journal:  Jpn J Pharmacol       Date:  1977-04

3.  Studies on a new 1, 5-benzothiazepine derivative (CRD-401). II. Vasodilator actions.

Authors:  T Nagao; M Sato; H Nakajima; A Kiyomoto
Journal:  Jpn J Pharmacol       Date:  1972-02

4.  Effects of calcium, sodium and potassium ions on contractility of isolated atria and their responses to noradrenaline.

Authors:  N Toda
Journal:  Br J Pharmacol       Date:  1969-06       Impact factor: 8.739

5.  Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).

Authors:  M Sato; T Nagao; I Yamaguchi; H Nakajima; A Kiyomoto
Journal:  Arzneimittelforschung       Date:  1971-09

6.  Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions.

Authors:  K Yamada; T Shimamura; H Nakajima
Journal:  Jpn J Pharmacol       Date:  1973-06

7.  Effects of diltiazem and lanthanum ion on the potassium contracture of isolated guinea pig smooth muscle.

Authors:  T Magaribuchi; H Nakajima; A Kiyomoto
Journal:  Jpn J Pharmacol       Date:  1977-06

8.  Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields.

Authors:  W G Nayler; I McInnes; J B Swann; V Carson; T E Lowe
Journal:  Am Heart J       Date:  1967-02       Impact factor: 4.749

9.  Electrical and mechanical responses to diltiazem in potassium depolarized myocardium of the guinea pig.

Authors:  H Nakajima; M Hoshiyama; K Yamashita; A Kiyomoto
Journal:  Jpn J Pharmacol       Date:  1976-10

10.  Some effects of iproveratril (Isoptin) on the cardiovascular system.

Authors:  W G Nayler; I McInnes; J B Swann; J M Price; V Carson; D Race; T E Lowe
Journal:  J Pharmacol Exp Ther       Date:  1968-06       Impact factor: 4.030

View more
  3 in total

1.  Studies on the calcium antagonistic action of tetrandrine: IV. Effects of tetrandrine on isoproterenol and calcium-mediated positive chronotropic action in isolated rabbit atria.

Authors:  D C Fang; W X Yao; G J Xia; M X Jiang
Journal:  Acta Acad Med Wuhan       Date:  1984

Review 2.  Diltiazem.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1985-01

3.  Attenuation by diltiazem of arterial baroreflex sensitivity in man.

Authors:  J F Giudicelli; A Berdeaux; A Edouard; F Lhoste; C Richer; C Thuillez; A Jacolot
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.